Abstract:
Objective To investigate the expression of the long non-coding RNA (lncRNA) FER1L4 in renal cell carcinoma tissues and its role in the proliferation, invasion, and migration of renal cell carcinoma cells in vitro.
Methods The expression level of lncRNA FER1L4 in 523 renal cancer tissues and 100 paracancerous tissues and the relationship between lncRNA FER1L4 expression level in tissue samples from 516 renal cancer patients and the prognoses were analyzed using the GEPIA database. Tumor tissue and paracancerous tissue samples were collected from 65 renal cell carcinoma patients under treatment at The First Affiliated Hospital of Nanchang University from January 2020 to January 2021. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression level of LncRNA FER1L4 in renal cell carcinoma tissues and cells, and the correlation between LncRNA FER1L4 expression and clinicopathological characteristics of patients were analyzed. LncRNA FER1L4-silenced 786-O and OSRC2 renal cell carcinoma cell lines were established. The effects of lncRNA FER1L4 on the proliferation, invasion, and migration of these cell lines in vitro were determined using the CCK8, wound healing, Transwell, and colony formation assays. Changes in the expression levels of proteins related to epithelial-mesenchymal transition (EMT) were detected by Western blot.
Results The results of the GEPIA database analysis showed that lncRNA FER1L4 expression was significantly higher in the renal cell carcinoma than in the matched paracancerous tissues and that its expression negatively correlated with survival (P<0.001). RT-qPCR results showed that lncRNA FER1L4 expression in renal cell carcinoma tissues of 65 patients (8.63 ± 1.79) was significantly higher than that in the matched adjacent tissues (1.84±0.95; P<0.001). The high lncRNA FER1L4 expression in the renal cell carcinoma tissues significantly correlated with the tumor diameter, tumor stage, lymph node metastasis, and distant metastasis (all P<0.05). Results of the CCK8, wound healing, Transwell, and colony formation assays showed that the proliferation, migration, and invasion ability of the 786-O and OSRC2 cells were significantly reduced after LncRNA FER1L4 silencing (P<0.05). Western blot results showed that Vimentin and N-cadherin were down-regulated, while E-cadherin was up-regulated in the LncRNA FER1L4-silenced 786-O and OSRC2 cells (P<0.05).
Conclusions LncRNA FER1L4 was highly expressed in renal cell carcinoma, correlating with tumor diameter, tumor stage, lymphatic metastasis, and distant metastasis. The promoting effect of LncRNA FER1L4 on renal cell carcinoma progression might be partially related to EMT.